AMT Medical Secures €22M to Revolutionize Heart Bypass Surgery
Netherlands, Thursday, 17 April 2025.
AMT Medical raised €22 million to advance their ELANA® system, a technology enabling coronary artery bypass grafting without opening the chest or stopping the heart, aiming to halve traditional costs.
Innovative Medical Technology Breakthrough
AMT Medical, established in 2017 and based in Ede and Utrecht, Netherlands, has developed the revolutionary ELANA® Heart Bypass System [1][2]. With 27 employees and over 40 patents for its beating-heart surgical platform, the company has positioned itself at the forefront of cardiovascular innovation [3]. The system employs a proprietary sutureless anastomosis technique utilizing a specialized clip and excimer laser to connect blood vessels, eliminating the need for manual suturing [2].
Significant Cost and Recovery Benefits
The ELANA® system promises to reduce costs associated with coronary artery bypass grafting (CABG) procedures by over 50% when implemented in a robotic setting [2]. This substantial reduction stems from shorter operating room times, decreased hospital stays, and fewer complications [2]. The technology enables procedures through small chest incisions without stopping the heart, significantly reducing stroke risks and postoperative recovery periods [3]. Currently, the system is being tested in clinical settings at St. Antonius Hospital in Nieuwegein and the German Heart Centre in Berlin [1].
Future Development and Market Entry
The secured funding will drive several key initiatives, including the completion of AMT Medical’s European first-in-human trial, which is evaluating the system during open chest CABG procedures with a beating heart [4]. Results from these trials are expected by the end of 2025, with CE Marking anticipated by 2026 [5]. The company plans to initiate clinical trials in the United States for both open and robotic settings [2]. This innovation could potentially benefit up to 1 million patients annually by reducing reliance on traditional open-heart surgeries [5].